Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satavaptan vs placebo in SIADH-related dilutional hyponatremia
2007-007941-10Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of satavaptan in hyponatraemia and syndrome of inappropriate antidiuresis (SIAD) (3 arms), sponsored by Sanofi. Primary endpoint: Primary: Change in serum sodium at Day 5 (pre-dose). Started Apr 2008; status: terminated.
02
Drugs
satavaptan
03
Conditions
hyponatraemiasyndrome of inappropriate antidiuresis (SIAD)
Beyond the preview
Go deeper on 2007-007941-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007941-10.